A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects

NCT07671833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: LY03015 (LPM3770164 extended-release tablets)

Sponsor

Luye Pharma Group Ltd.